Rcn Pareto Strategic Allocation ETF (PRTO)
Rcn Pareto Strategic Allocation ETF (PRTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PRTO | RGNT | ALLR | ||
| Company | Rcn Pareto Strategic Allocation ETF | Regentis Biomaterials Ltd | Allarity Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NYSE Arca | NYSE Arca | NASDAQ | ||
| Open | 27.62 | 3.59 | 1.1400 | ||
| High | 27.62 | 3.77 | 1.2000 | ||
| Low | 27.62 | 3.50 | 1.1400 | ||
| Latest | 27.62 | 3.64 | 1.2000 | ||
| Change | +0.29 | +0.06 | +0.0400 | ||
| % Change | +1.05% | +1.68% | +3.45% | ||
| Volume | 100 | 75,500 | 55,700 | ||
| 20-Day Average Volume | 1,330 | 10,783,665 | 165,290 | ||
| Previous Close | 27.34 | 3.58 | 1.1600 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 27.58 | 4.05 | 1.3310 | ||
| 20-Day Raw Stochastic | 59.84% | 15.71% | 27.32% | ||
| 20-Day Relative Strength | 52.25 | 51.23 | 41.73 | ||
| Weighted Alpha | N/A | -80.96 | -33.46 | ||
| Today's Opinion | N/A | N/A | 8% Sell | ||
| Previous Opinion | N/A | N/A | 8% Sell | ||
| Last Month's Opinion | N/A | N/A | 72% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.08% since 07/01/26 | -20.35% since 07/01/26 | -9.77% since 07/01/26 | ||
| Low | 27.24 on 07/08/26 | 3.50 on 07/09/26 | 1.0350 on 07/07/26 | ||
| High | 27.79 on 07/06/26 | 4.54 on 07/02/26 | 1.4000 on 07/02/26 | ||
| 1-Month | |||||
| %Chg | +1.46% since 06/09/26 | +51.04% since 06/09/26 | -25.47% since 06/09/26 | ||
| Low | 26.82 on 06/10/26 | 1.43 on 06/10/26 | 1.0350 on 07/07/26 | ||
| High | 28.16 on 06/15/26 | 15.50 on 06/15/26 | 1.6390 on 06/10/26 | ||
| 3-Month | |||||
| %Chg | +5.13% since 04/09/26 | +19.15% since 04/09/26 | +4.35% since 04/09/26 | ||
| Low | 26.16 on 04/10/26 | 1.23 on 06/08/26 | 1.0350 on 07/07/26 | ||
| High | 28.16 on 06/15/26 | 15.50 on 06/15/26 | 1.8395 on 05/27/26 | ||
| 6-Month | |||||
| %Chg | N/A since 03/25/26 | -45.02% since 01/09/26 | +2.56% since 01/09/26 | ||
| Low | 24.68 on 03/30/26 | 1.23 on 06/08/26 | 0.7687 on 02/03/26 | ||
| High | 28.16 on 06/15/26 | 15.50 on 06/15/26 | 1.8395 on 05/27/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 18,524 | 18,542 | 18,457 | ||
| Shares Outstanding, K | 22,179 | 5,179 | 15,911 | ||
| Annual Sales | 0 | 0 | 320,000 | ||
| Annual Net Income | -20,730,000 | -13,650,000 | -11,230,000 | ||
| Last Quarter Sales | N/A | N/A | 30,000 | ||
| Last Quarter Net Income | N/A | N/A | -2,750,000 | ||
| 60-Month Beta | 0.60 | N/A | 0.53 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | N/A | -0.17 on 05/15/26 | ||
| Earnings Date | 03/11/20 | 06/30/26 | 08/21/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||